{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT02260375",
      "OrgStudyIdInfo": {
        "OrgStudyId": "MSC liver transplant tolerance"
      },
      "SecondaryIdInfoList": {
        "SecondaryIdInfo": [
          {
            "SecondaryId": "2014-001531-37",
            "SecondaryIdType": "EudraCT Number"
          }
        ]
      },
      "Organization": {
        "OrgFullName": "A.O. Ospedale Papa Giovanni XXIII",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "MSC Therapy in Liver Transplantation",
      "OfficialTitle": "THIRD-PARTY BONE MARROW-DERIVED MESENCHYMAL STROMAL CELLS TO INDUCE TOLERANCE IN LIVER TRANSPLANT RECIPIENTS"
    },
    "StatusModule": {
      "StatusVerifiedDate": "April 2018",
      "OverallStatus": "Recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "October 2014"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "October 2024",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "October 2025",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "October 6, 2014",
      "StudyFirstSubmitQCDate": "October 8, 2014",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "October 9, 2014",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "April 5, 2018",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "April 6, 2018",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor-Investigator",
        "ResponsiblePartyInvestigatorFullName": "Monia Lorini",
        "ResponsiblePartyInvestigatorTitle": "EC Secretary",
        "ResponsiblePartyInvestigatorAffiliation": "A.O. Ospedale Papa Giovanni XXIII"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Monia Lorini",
        "LeadSponsorClass": "OTHER"
      },
      "CollaboratorList": {
        "Collaborator": [
          {
            "CollaboratorName": "Mario Negri Institute for Pharmacological Research",
            "CollaboratorClass": "OTHER"
          }
        ]
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "The general aim of the present study is to test a cell therapy with third-party allogeneic ex-vivo expanded MSCs as a strategy to induce tolerance in liver transplant recipients. MSCs will be prepared accordingly to established protocols , starting from diagnostic samples of bone marrow aspirates (2-5 mL) or using the remnants in the bag and filter at the end of the bone marrow infusions. From these samples, MSCs will be expanded in GMP approved facilities and used for the present study in patients undergoing liver transplantation."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Liver Transplant Rejection"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Mesenchymal stromal cells; liver transplantation; tolerance."
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "20",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Mesenchymal Stromal Cells (MSC)",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "A single intravenous infusion (1-2 millions of MSCs per kilogram body weight) of ex-vivo expanded third-party MSC (from healthy donors) will be performed in patients assigned to the MSC procedure in addition to the liver transplantation.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Mesenchymal Stromal Cells"
              ]
            }
          },
          {
            "ArmGroupLabel": "No treatment.",
            "ArmGroupType": "No Intervention"
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "Mesenchymal Stromal Cells",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Mesenchymal Stromal Cells (MSC)"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Number of adverse events",
            "PrimaryOutcomeDescription": "At each visit overall clinical condition of the patient will be evaluated and any adverse event will be recorded.",
            "PrimaryOutcomeTimeFrame": "Changes from baseline up to 120 month."
          },
          {
            "PrimaryOutcomeMeasure": "Liver tissue mRNA level of Transferrin receptor CD71 (TFRC) and Hepcidin antimicrobial peptide (HAMP) genes",
            "PrimaryOutcomeTimeFrame": "At 12 and 60 month."
          },
          {
            "PrimaryOutcomeMeasure": "Circulating naive and memory T cell conts (CD45RA/CD45RO)(flow cytometry analysis)",
            "PrimaryOutcomeTimeFrame": "Changes from baseline at 6 and 12 months after transplant, then every 6 months till the first 3 years after transplant and then yearly up to 120 month."
          },
          {
            "PrimaryOutcomeMeasure": "T-cell function in mixed lymphocyte reaction",
            "PrimaryOutcomeTimeFrame": "Changes from baseline at 6 and 12 months after transplant, then every 6 months till the first 3 years after transplant and then yearly up to 120 month."
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nFor this study, the following inclusion criteria should be fulfilled before starting withdrawal of drugs after 1 year post-transplant:\n\nFirst liver transplant\nCapable of understanding the purpose and risk of the study\nWritten informed consent\n\nExclusion Criteria:\n\nSpecific contraindication to MSC infusion\nAny clinical relevant condition that might affect study participation and/or study results\nPregnant women and nursing mothers\nUnwillingness or inability to follow the study protocol in the investigator's opinion.",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "CentralContactList": {
        "CentralContact": [
          {
            "CentralContactName": "Giuseppe Remuzzi, MD",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "0039 0352674037",
            "CentralContactEMail": "gremuzzi@hpg23.it"
          }
        ]
      },
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Giuseppe Remuzzi, MD",
            "OverallOfficialAffiliation": "A.O. Ospedale Papa Giovanni XXIII",
            "OverallOfficialRole": "Study Chair"
          },
          {
            "OverallOfficialName": "Norberto Perico, MD",
            "OverallOfficialAffiliation": "IRCCS-Istituto di Ricerche Farmacologiche M. Negri",
            "OverallOfficialRole": "Study Director"
          },
          {
            "OverallOfficialName": "Michele Colledan, MD",
            "OverallOfficialAffiliation": "A.O. Ospedale Papa Giovanni XXIII",
            "OverallOfficialRole": "Principal Investigator"
          },
          {
            "OverallOfficialName": "Stefano Fagiuoli, MD",
            "OverallOfficialAffiliation": "A.O. Ospedale Papa Giovanni XXIII",
            "OverallOfficialRole": "Principal Investigator"
          },
          {
            "OverallOfficialName": "Martino Introna, MD",
            "OverallOfficialAffiliation": "Laboratorio G.Lanzani, Bergamo, Italy",
            "OverallOfficialRole": "Principal Investigator"
          },
          {
            "OverallOfficialName": "Alessandro Rambaldi, MD",
            "OverallOfficialAffiliation": "A.O. Ospedale Papa Giovanni XXIII",
            "OverallOfficialRole": "Principal Investigator"
          },
          {
            "OverallOfficialName": "Antonio Pinna, MD",
            "OverallOfficialAffiliation": "Policlinico S. Orsola Bologna, Italy",
            "OverallOfficialRole": "Principal Investigator"
          },
          {
            "OverallOfficialName": "Claudio Velati, MD",
            "OverallOfficialAffiliation": "Policlinico S. Orsola Bologna, Italy",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "U.S.C Nefrologia e Dialisi",
            "LocationStatus": "Recruiting",
            "LocationCity": "Bergamo",
            "LocationZip": "24127",
            "LocationCountry": "Italy",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Giuseppe Remuzzi, MD",
                  "LocationContactRole": "Contact",
                  "LocationContactPhone": "0039 0352674037",
                  "LocationContactEMail": "gremuzzi@hpg23.it"
                },
                {
                  "LocationContactName": "Giuseppe Remuzzi, MD",
                  "LocationContactRole": "Principal Investigator"
                }
              ]
            }
          },
          {
            "LocationFacility": "USC Chirurgia Generale III",
            "LocationStatus": "Recruiting",
            "LocationCity": "Bergamo",
            "LocationZip": "24127",
            "LocationCountry": "Italy",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Michele Colledan, Md",
                  "LocationContactRole": "Contact",
                  "LocationContactPhone": "00390352674347",
                  "LocationContactEMail": "mcolledan@hpg23.it"
                },
                {
                  "LocationContactName": "Marco Zambelli, MD",
                  "LocationContactRole": "Principal Investigator"
                }
              ]
            }
          },
          {
            "LocationFacility": "USC Ematologia",
            "LocationStatus": "Recruiting",
            "LocationCity": "Bergamo",
            "LocationZip": "24127",
            "LocationCountry": "Italy",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Alessandro Rambaldi, MD",
                  "LocationContactRole": "Contact",
                  "LocationContactPhone": "00390352673684",
                  "LocationContactEMail": "arambaldi@hpg23.it"
                },
                {
                  "LocationContactName": "Alessandro Rambaldi, MD",
                  "LocationContactRole": "Sub-Investigator"
                }
              ]
            }
          },
          {
            "LocationFacility": "USC Gastroenterologia",
            "LocationStatus": "Recruiting",
            "LocationCity": "Bergamo",
            "LocationZip": "24127",
            "LocationCountry": "Italy",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Stefano Fagiuoli, MD",
                  "LocationContactRole": "Contact",
                  "LocationContactPhone": "00390352674259",
                  "LocationContactEMail": "sfagiuoli@hpg23.it"
                },
                {
                  "LocationContactName": "Giulia Magini, MD",
                  "LocationContactRole": "Sub-Investigator"
                }
              ]
            }
          },
          {
            "LocationFacility": "Servizio di Immunoematologia e Medicina Trasfusionale",
            "LocationStatus": "Recruiting",
            "LocationCity": "Bologna",
            "LocationZip": "40138",
            "LocationCountry": "Italy",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Claudio Velati, MD",
                  "LocationContactRole": "Contact"
                },
                {
                  "LocationContactName": "Marina Buzzi, MD",
                  "LocationContactRole": "Contact"
                },
                {
                  "LocationContactName": "Claudio Velati, MD",
                  "LocationContactRole": "Sub-Investigator"
                }
              ]
            }
          },
          {
            "LocationFacility": "Unità Chirurgia Generale e Trapianti",
            "LocationStatus": "Recruiting",
            "LocationCity": "Bologna",
            "LocationZip": "40138",
            "LocationCountry": "Italy",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Antonio Pinna, MD",
                  "LocationContactRole": "Contact"
                },
                {
                  "LocationContactName": "Antonio Pinna, MD",
                  "LocationContactRole": "Principal Investigator"
                }
              ]
            }
          }
        ]
      }
    },
    "ReferencesModule": {
      "ReferenceList": {
        "Reference": [
          {
            "ReferencePMID": "33370477",
            "ReferenceType": "derived",
            "ReferenceCitation": "Casiraghi F, Perico N, Podestà MA, Todeschini M, Zambelli M, Colledan M, Camagni S, Fagiuoli S, Pinna AD, Cescon M, Bertuzzo V, Maroni L, Introna M, Capelli C, Golay JT, Buzzi M, Mister M, Ordonez PYR, Breno M, Mele C, Villa A, Remuzzi G; MSC-LIVER Study Group. Third-party bone marrow-derived mesenchymal stromal cell infusion before liver transplantation: A randomized controlled trial. Am J Transplant. 2021 Aug;21(8):2795-2809. doi: 10.1111/ajt.16468. Epub 2021 Feb 22."
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "InterventionBrowseModule": {
      "InterventionBrowseLeafList": {
        "InterventionBrowseLeaf": [
          {
            "InterventionBrowseLeafId": "M10262",
            "InterventionBrowseLeafName": "Liver Extracts",
            "InterventionBrowseLeafRelevance": "low"
          }
        ]
      },
      "InterventionBrowseBranchList": {
        "InterventionBrowseBranch": [
          {
            "InterventionBrowseBranchAbbrev": "Hemat",
            "InterventionBrowseBranchName": "Hematinics"
          },
          {
            "InterventionBrowseBranchAbbrev": "All",
            "InterventionBrowseBranchName": "All Drugs and Chemicals"
          }
        ]
      }
    }
  }
}